Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1
62 participants
INTERVENTIONAL
2016-10-31
2021-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Examine the Feasibility of a Standardized Field Test for Marijuana Impairment: Laboratory Evaluations
NCT03191084
Standardized Field Test for Marijuana Impairment II
NCT05115513
Cannabis Observations on Brain Waves, Retrieval, and Attention: Experiment 1
NCT05868213
Examine the Feasibility of a Standardized Field Test for Marijuana and Alcohol Impairment: Laboratory Evaluations
NCT04856566
Neuroimaging of Adolescent Cannabis Use Treatment
NCT07340554
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
OTHER
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Regular Users
People who use marijuana regularly will be given a low dose THC marijuana, high dose THC marijuana and placebo marijuana, in a randomized order, at the study visits.
Low dose THC marijuana
High dose THC marijuana
Placebo marijuana
Occasional Users
People who use marijuana occasionally will be given a low dose THC marijuana, high dose THC marijuana and placebo marijuana, in a randomized order, at the study visits.
Low dose THC marijuana
High dose THC marijuana
Placebo marijuana
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Low dose THC marijuana
High dose THC marijuana
Placebo marijuana
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have used marijuana before
* Right handed
Exclusion Criteria
* Unable or unsafe to have an MRI
* Any serious medical, or neurological disorder
* Any psychiatric disorder
* No major head traumas
18 Years
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hartford Hospital
OTHER
National Institute on Drug Abuse (NIDA)
NIH
Montana State University
OTHER
Maastricht University
OTHER
The Mind Research Network
OTHER
Yale University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Godfrey Pearlson
Founding Director Olin Neuropsychiatry Research Center; Professor Yale University
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Godfrey Pearlson
Role: PRINCIPAL_INVESTIGATOR
Founding Director Olin Research Center; Professor Yale University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Olin Neuropsychiatry Research Center
Hartford, Connecticut, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1507016175
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.